User menu

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice

  • Open access
  • PDF
  • 886.69 K
  1. Desvergne B., Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism, 10.1210/er.20.5.649
  2. Bisogno T., Delton-Vandenbroucke I., Milone A., Lagarde M., Di Marzo V., Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina, 10.1006/abbi.1999.1410
  3. Guzmán Manuel, Lo Verme Jesse, Fu Jin, Oveisi Fariba, Blázquez Cristina, Piomelli Daniele, Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α), 10.1074/jbc.m404087200
  4. Diep T. A., Madsen A. N., Holst B., Kristiansen M. M., Wellner N., Hansen S. H., Hansen H. S., Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor, 10.1096/fj.10-166595
  5. Thabuis Clémentine, Destaillats Frédéric, Landrier Jean-François, Tissot-Favre Delphine, Martin Jean-Charles, Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice☆, 10.1016/j.jnutbio.2009.07.006
  6. Navarro Virginia, Portillo María P., Margotat Alain, Landrier Jean-François, Macarulla Maria T., Lairon Denis, Martin Jean-Charles, A multi-gene analysis strategy identifies metabolic pathways targeted by trans-10, cis-12-conjugated linoleic acid in the liver of hamsters, 10.1017/s0007114509231734
  7. Oltvai Z. N., SYSTEMS BIOLOGY: Life's Complexity Pyramid, 10.1126/science.1078563
  8. Kleemann Robert, van Erk Marjan, Verschuren Lars, van den Hoek Anita M., Koek Maud, Wielinga Peter Y., Jie Annie, Pellis Linette, Bobeldijk-Pastorova Ivana, Kelder Thomas, Toet Karin, Wopereis Suzan, Cnubben Nicole, Evelo Chris, van Ommen Ben, Kooistra Teake, Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance, 10.1371/journal.pone.0008817
  9. Wold Svante, Kettaneh Nouna, Tjessem Kjell, Hierarchical multiblock PLS and PC models for easier model interpretation and as an alternative to variable selection, 10.1002/(sici)1099-128x(199609)10:5/6<463::aid-cem445>3.0.co;2-l
  10. Shannon P., Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks, 10.1101/gr.1239303
  11. Astarita G., Pharmacological Characterization of Hydrolysis-Resistant Analogs of Oleoylethanolamide with Potent Anorexiant Properties, 10.1124/jpet.106.105221
  12. Terpstra, J. Nutr., 131, 2067 (2001)
  13. Yang Y., Chen M., Georgeson K. E., Harmon C. M., Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction, 10.1152/ajpregu.00270.2006
  14. McGarry J D, Foster D W, Regulation of Hepatic Fatty Acid Oxidation and Ketone Body Production, 10.1146/annurev.bi.49.070180.002143
  15. Kotz C. M., Teske J. A., Billington C. J., Neuroregulation of nonexercise activity thermogenesis and obesity resistance, 10.1152/ajpregu.00095.2007
  16. Cani Patrice D., Montoya Maite Lasa, Neyrinck Audrey M., Delzenne Nathalie M., Lambert Didier M., Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide, 10.1079/bjn20041256
  17. Nielsen Mie Julin, Petersen Gitte, Astrup Arne, Hansen Harald S., Food intake is inhibited by oral oleoylethanolamide, 10.1194/jlr.c300008-jlr200
  18. Popeijus H E, Saris W H M, Mensink R P, Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome, 10.1038/ijo.2008.55
  19. Ntambi J. M., Miyazaki M., Stoehr J. P., Lan H., Kendziorski C. M., Yandell B. S., Song Y., Cohen P., Friedman J. M., Attie A. D., Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity, 10.1073/pnas.132384699
  20. Terrazzino S., Stearoylethanolamide exerts anorexic effects in mice via downregulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression, 10.1096/fj.03-1080fje
  21. Serrano Antonia, del Arco Ignacio, Javier Pavón Francisco, Macías Manuel, Perez-Valero Vidal, Rodríguez de Fonseca Fernando, The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats, 10.1016/j.neuropharm.2007.03.007
  22. Miyazaki, J. Lipid Res., 42, 1018 (2001)
  23. Van Wymelbeke, Am. J. Clin. Nutr., 74, 620 (2001)
  24. Sun Yong-Xin, Tsuboi Kazuhito, Zhao Li-Ying, Okamoto Yasuo, Lambert Didier M., Ueda Natsuo, Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages, 10.1016/j.bbalip.2005.08.010
  25. Fegley D., Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation, 10.1124/jpet.104.078980
  26. Thabuis Clémentine, Tissot-Favre Delphine, Bezelgues Jean-Baptiste, Martin Jean-Charles, Cruz-Hernandez Cristina, Dionisi Fabiola, Destaillats Frédéric, Biological Functions and Metabolism of Oleoylethanolamide, 10.1007/s11745-008-3217-y
  27. Lo Verme J., Gaetani S., Fu J., Oveisi F., Burton K., Piomelli D., Regulation of food intake by oleoylethanolamide, 10.1007/s00018-004-4494-0
  28. Rodríguez de Fonseca F., Navarro M., Gómez R., Escuredo L., Nava F., Fu J., Murillo-Rodríguez E., Giuffrida A., LoVerme J., Gaetani S., Kathuria S., Gall C., Piomelli D., An anorexic lipid mediator regulated by feeding, 10.1038/35102582
  29. Fu Jin, Gaetani Silvana, Oveisi Fariba, Lo Verme Jesse, Serrano Antonia, Rodríguez de Fonseca Fernando, Rosengarth Anja, Luecke Hartmut, Di Giacomo Barbara, Tarzia Giorgio, Piomelli Daniele, Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α, 10.1038/nature01921
  30. Fu Jin, Oveisi Fariba, Gaetani Silvana, Lin Edward, Piomelli Daniele, Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats, 10.1016/j.neuropharm.2005.02.013
Bibliographic reference Thabuis, Clémentine ; Destaillats, Frédéric ; Lambert, Didier ; Muccioli, Giulio ; Maillot, Matthieu ; et. al. Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice. In: Journal of Lipid Research, Vol. 52, no. 7, p. 1373-82 (2011)
Permanent URL http://hdl.handle.net/2078.1/106001